BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 18443575)

  • 21. Association of asymmetric dimethylarginine with severity of kidney injury and decline in kidney function in IgA nephropathy.
    Fujimi-Hayashida A; Ueda S; Yamagishi S; Kaida Y; Ando R; Nakayama Y; Fukami K; Okuda S
    Am J Nephrol; 2011; 33(1):1-6. PubMed ID: 21109733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Arginine/asymmetric dimethylarginine ratio and cardiovascular risk factors in patients with predialytic chronic kidney disease.
    Hov GG; Sagen E; Hatlen G; Bigonah A; Åsberg A; Aasarød K
    Clin Biochem; 2011 Jun; 44(8-9):642-6. PubMed ID: 21406191
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between asymmetric dimethylarginine and indices of vascular function in patients with essential hypertension.
    Serg M; Kampus P; Kals J; Zagura M; Muda P; Tuomainen TP; Zilmer K; Salum E; Zilmer M; Eha J
    Blood Press; 2011 Apr; 20(2):111-6. PubMed ID: 21142418
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal resistance index in renal allograft recipients: a role for ADMA.
    Bergmann IP; Böger RH; Marti E; Frey FJ; Schwedhelm E; Eisenberger U
    Am J Kidney Dis; 2009 Aug; 54(2):327-33. PubMed ID: 19560848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relations between plasma asymmetric dimethylarginine (ADMA) and risk factors for coronary disease.
    Wang J; Sim AS; Wang XL; Salonikas C; Naidoo D; Wilcken DE
    Atherosclerosis; 2006 Feb; 184(2):383-8. PubMed ID: 15939423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Level of asymmetric dimethylarginine and carotid atherosclerosis in patients with chronic kidney disease.
    Zhang WR; Hou FF; Ning JP; Yang XB; Wu Q; Tao LJ; Chen BM; Li HY; Chang L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 31(5):621-8. PubMed ID: 17062918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of uric acid on coronary microvascular endothelial function in women: association with eGFR and ADMA.
    Kuwahata S; Hamasaki S; Ishida S; Kataoka T; Yoshikawa A; Orihara K; Ogawa M; Oketani N; Saihara K; Okui H; Shinsato T; Kubozono T; Ichiki H; Fujita S; Takumi T; Yoshino S; Nakazaki M; Miyata M; Tei C
    J Atheroscler Thromb; 2010 Mar; 17(3):259-69. PubMed ID: 20228613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vascular endothelial cell activation associated with increased plasma asymmetric dimethyl arginine in children and young adults with hypertension: a basis for atheroma?
    Goonasekera CD; Shah V; Rees DD; Dillon MJ
    Blood Press; 2000; 9(1):16-21. PubMed ID: 10854003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Asymmetric dimethylarginine and progression of chronic kidney disease: a one-year follow-up study.
    Eiselt J; Rajdl D; Racek J; Vostrý M; Rulcová K; Wirth J
    Kidney Blood Press Res; 2014; 39(1):50-7. PubMed ID: 24923294
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased levels of asymmetric dimethylarginine and C-reactive protein are associated with impaired vascular reactivity in essential hypertension.
    Xia W; Feng W; Guan M; Yu Y; Li J; Qu X
    Clin Exp Hypertens; 2010 Jan; 32(1):43-8. PubMed ID: 20144072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma asymmetric dimethylarginine and L-arginine levels in patients with cardiac syndrome X.
    Okyay K; Cengel A; Sahinarslan A; Tavil Y; Turkoglu S; Biberoglu G; Hasanoglu A
    Coron Artery Dis; 2007 Nov; 18(7):539-44. PubMed ID: 17925607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytomegalovirus infection impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine in transplant arteriosclerosis.
    Weis M; Kledal TN; Lin KY; Panchal SN; Gao SZ; Valantine HA; Mocarski ES; Cooke JP
    Circulation; 2004 Feb; 109(4):500-5. PubMed ID: 14732750
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Left ventricular hypertrophy, cardiac remodeling and asymmetric dimethylarginine (ADMA) in hemodialysis patients.
    Zoccali C; Mallamaci F; Maas R; Benedetto FA; Tripepi G; Malatino LS; Cataliotti A; Bellanuova I; Böger R;
    Kidney Int; 2002 Jul; 62(1):339-45. PubMed ID: 12081596
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suppression of endothelial progenitor cells in human coronary artery disease by the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine.
    Thum T; Tsikas D; Stein S; Schultheiss M; Eigenthaler M; Anker SD; Poole-Wilson PA; Ertl G; Bauersachs J
    J Am Coll Cardiol; 2005 Nov; 46(9):1693-701. PubMed ID: 16256870
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Asymmetric dimethylarginine (ADMA): a cardiovascular and renal risk factor on the move.
    Zoccali C
    J Hypertens; 2006 Apr; 24(4):611-9. PubMed ID: 16531785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of asymmetrical dimethylarginine in renal microvascular endothelial dysfunction in chronic renal failure with hypertension.
    Okubo K; Hayashi K; Wakino S; Matsuda H; Kubota E; Honda M; Tokuyama H; Yamamoto T; Kajiya F; Saruta T
    Hypertens Res; 2005 Feb; 28(2):181-9. PubMed ID: 16025746
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Asymmetric dimethylarginine and hemodynamic regulation in middle-aged men.
    Päivä H; Laakso J; Kähönen M; Turjanmaa V; Kööbi T; Majahalme S; Lehtimäki T; Ruokonen I; Laaksonen R
    Metabolism; 2006 Jun; 55(6):771-7. PubMed ID: 16713437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated asymmetric dimethylarginine is associated with oxidant stress aggravation in patients with early stage autosomal dominant polycystic kidney disease.
    Raptis V; Georgianos PI; Sarafidis PA; Sioulis A; Makedou K; Makedou A; Grekas DM; Kapoulas S
    Kidney Blood Press Res; 2013; 38(1):72-82. PubMed ID: 24577239
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An association between plasma asymmetric dimethylarginine and membrane fluidity of erythrocytes in hypertensive and normotensive men: an electron paramagnetic resonance investigation.
    Tsuda K; Nishio I
    Am J Hypertens; 2005 Sep; 18(9 Pt 1):1243-8. PubMed ID: 16182117
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The determinants of endothelial dysfunction in CKD: oxidative stress and asymmetric dimethylarginine.
    Yilmaz MI; Saglam M; Caglar K; Cakir E; Sonmez A; Ozgurtas T; Aydin A; Eyileten T; Ozcan O; Acikel C; Tasar M; Genctoy G; Erbil K; Vural A; Zoccali C
    Am J Kidney Dis; 2006 Jan; 47(1):42-50. PubMed ID: 16377384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.